A twice-yearly HIV prevention shot just got significantly more affordable. The US Food and Drug Administration has approved a low-cost version of the breakthrough drug, a move that could change the reality of HIV prevention for millions of people in low-income countries, including across Africa.
The original shot, administered just twice a year, was already considered a game-changer in the fight against HIV. A cheaper version opening the door to wider distribution means that communities historically priced out of cutting-edge prevention tools may finally have access to one.
For a continent where HIV remains one of the most pressing public health challenges, this approval carries real weight. The path from FDA approval to actual availability in Nigerian clinics or Kenyan health centres involves many more steps, but this is the kind of news that makes those steps feel worth watching.
Originally published by AllAfrica.